Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,156 | 1,560 | 99.4% |
| Education | $180.89 | 11 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $4,095 | 184 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $3,487 | 97 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,434 | 106 | $0 (2024) |
| Lilly USA, LLC | $2,395 | 171 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,830 | 104 | $0 (2024) |
| ABBVIE INC. | $1,768 | 111 | $0 (2024) |
| PFIZER INC. | $1,734 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,159 | 51 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $1,146 | 43 | $0 (2023) |
| Amgen Inc. | $1,104 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,195 | 157 | Novo Nordisk Inc ($490.66) |
| 2023 | $3,921 | 185 | Novo Nordisk Inc ($490.98) |
| 2022 | $3,491 | 163 | Janssen Pharmaceuticals, Inc ($412.19) |
| 2021 | $3,318 | 177 | Novo Nordisk Inc ($594.71) |
| 2020 | $2,537 | 156 | Novo Nordisk Inc ($411.23) |
| 2019 | $4,483 | 223 | Novo Nordisk Inc ($761.96) |
| 2018 | $4,810 | 231 | Janssen Pharmaceuticals, Inc ($838.16) |
| 2017 | $4,583 | 279 | Janssen Pharmaceuticals, Inc ($499.20) |
All Payment Transactions
1,571 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: GI | ||||||
| 12/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.47 | General |
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Biological | ||||||
| 11/26/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 10/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 4,160 | 6,642 | $621,862 | $230,768 |
| 2022 | 40 | 4,239 | 6,778 | $621,806 | $231,927 |
| 2021 | 37 | 4,001 | 6,572 | $517,703 | $202,301 |
| 2020 | 40 | 4,745 | 7,868 | $557,280 | $202,023 |
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 484 | 1,114 | $300,042 | $95,441 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 333 | 333 | $97,695 | $42,691 | 43.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 148 | 148 | $25,900 | $10,646 | 41.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 394 | 712 | $22,738 | $9,330 | 41.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 444 | 905 | $10,705 | $6,881 | 64.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 196 | 203 | $9,541 | $6,120 | 64.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 194 | 352 | $13,704 | $5,780 | 42.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 25 | $15,178 | $5,481 | 36.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 332 | 467 | $11,578 | $4,833 | 41.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 334 | 555 | $11,420 | $4,594 | 40.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 35 | 35 | $10,799 | $4,578 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 78 | $15,044 | $4,466 | 29.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 190 | 446 | $10,026 | $4,246 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 28 | $10,734 | $3,407 | 31.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 13 | $5,931 | $2,104 | 35.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 44 | 59 | $3,698 | $1,703 | 46.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 156 | 220 | $3,960 | $1,674 | 42.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 82 | 82 | $3,728 | $1,551 | 41.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 34 | 37 | $4,242 | $1,524 | 35.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 45 | 52 | $3,532 | $1,509 | 42.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $1,974 | $1,266 | 64.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,695 | $1,185 | 25.2% |
| 90471 | Administration of vaccine | Office | 2023 | 78 | 78 | $2,793 | $1,169 | 41.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 11 | $3,028 | $1,025 | 33.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 29 | $2,638 | $950.91 | 36.0% |
About Dr. Clinton Sutherland, MD
Dr. Clinton Sutherland, MD is a Internal Medicine healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487622320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clinton Sutherland, MD has received a total of $30,337 in payments from pharmaceutical and medical device companies, with $3,195 received in 2024. These payments were reported across 1,571 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($30,156).
As a Medicare-enrolled provider, Sutherland has provided services to 17,145 Medicare beneficiaries, totaling 27,860 services with total Medicare billing of $867,020. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Abingdon, VA
- Active Since 03/08/2006
- Last Updated 09/09/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487622320
Products in Payments
- XARELTO (Drug) $2,641
- Ozempic (Drug) $1,803
- JARDIANCE (Drug) $1,208
- TRULICITY (Drug) $1,128
- FARXIGA (Drug) $1,023
- TRELEGY ELLIPTA (Drug) $765.32
- INVOKANA (Drug) $694.32
- Aimovig (Biological) $636.17
- ENTRESTO (Drug) $633.45
- VRAYLAR (Drug) $618.63
- ELIQUIS (Drug) $605.45
- UBRELVY (Drug) $599.54
- BREZTRI (Drug) $596.93
- Wegovy (Drug) $553.57
- NURTEC ODT (Drug) $550.80
- Saxenda (Drug) $520.70
- MOUNJARO (Drug) $493.57
- Tresiba (Drug) $467.69
- AIRSUPRA (Drug) $376.93
- TRINTELLIX (Drug) $360.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Abingdon
Emory Robinette, M.d, M.D
Internal Medicine — Payments: $66,893
Haytham Adada, Md, MD
Internal Medicine — Payments: $10,638
Robert Jones, M.d, M.D
Internal Medicine — Payments: $10,385
Dr. Jonathan Swank, Md, MD
Internal Medicine — Payments: $6,901
Dr. William Baker, Md, MD
Internal Medicine — Payments: $4,876
Moe Mya, M.d, M.D
Internal Medicine — Payments: $4,505